Immunotherapy against Prion Disease
Open Access
- 14 March 2020
- Vol. 9 (3), 216
- https://doi.org/10.3390/pathogens9030216
Abstract
The term “prion disease” encompasses a group of neurodegenerative diseases affecting both humans and animals. Currently, there is no effective therapy and all forms of prion disease are invariably fatal. Because of (a) the outbreak of bovine spongiform encephalopathy in cattle and variant Creutzfeldt–Jakob disease in humans; (b) the heated debate about the prion hypothesis; and (c) the availability of a natural prion disease in rodents, the understanding of the pathogenic process in prion disease is much more advanced compared to that of other neurodegenerative disorders, which inspired many attempts to develop therapeutic strategies against these fatal diseases. In this review, we focus on immunotherapy against prion disease. We explain our rationale for immunotherapy as a plausible therapeutic choice, review previous trials using either active or passive immunization, and discuss potential strategies for overcoming the hurdles in developing a successful immunotherapy. We propose that immunotherapy is a plausible and practical therapeutic strategy and advocate more studies in this area to develop effective measures to control and treat these devastating disorders.Funding Information
- National Institutes of Health (R01NS110784)
This publication has 141 references indexed in Scilit:
- Anti-prion activity of an RNA aptamer and its structural basisNucleic Acids Research, 2012
- Cofactor molecules maintain infectious conformation and restrict strain properties in purified prionsProceedings of the National Academy of Sciences of the United States of America, 2012
- Sustained translational repression by eIF2α-P mediates prion neurodegenerationNature, 2012
- Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sitesNature Communications, 2011
- Generating a Prion with Bacterially Expressed Recombinant Prion ProteinScience, 2010
- Darwinian Evolution of Prions in Cell CultureScience, 2010
- Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomersNature, 2009
- High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated miceNeuroscience, 2008
- DNA Vaccination Can Break Immunological Tolerance to PrP in Wild-Type Mice and Attenuates Prion Disease after Intracerebral ChallengeJournal of Virology, 2006
- Clearance and prevention of prion infection in cell culture by anti‐PrP antibodiesEuropean Journal of Neuroscience, 2006